APR Applied Pharma Research s.a. , the Swiss, independent developer of science driven, patent protected healthcare products, is today proud to announce the business partnership with DKSH, the leading Market Expansion Services provider with a focus on Asia. The partnership involves marketing, sales, distribution and logistics for APR’s patented Diclofenac 50 mg powder oral solution for acute migraine treatment and other pain areas, in Malaysia, the Philippines, Myanmar and Vietnam under the DKSH subsidiary Favorex.
Category: Migraine
Acupuncture shows promise in migraine treatment, study says
When most people get a headache, a simple over-the-counter pain reliever and a few moments of quiet can usually do the trick. But for millions of Americans suffering from debilitating migraines, the pain can be so intense that relief may seem out of reach.
Botox now available on prescription for NHS Scotland
Campaigners welcomed the move, which will see patients receive injections of the muscle- paralysing toxin on their face, head and neck every 12 weeks to prevent the onset of migraines and reduce pain. It is thought that about 3,764 people in Scotland will be eligible for the treatment annually, at a cost of A 1,380 per patient.
Botox to be prescribed on NHS in Scotland for migraine patients
… of thousands of people suffering from headache and migraine in Scotland receive the best possible care throughout the health system.” Chronic migraines are defined as having at least 15 headaches per month lasting four or more hours – at least eight …
Migraine drugs may repeat rheumatoid arthritis success
… its first human infection of the strain since the former Portuguese colony returned to China in 1999. – – Children are more likely to become overweight or obese during summer vacation than during the school year, a U.S. study …